Top compounds associated with response to SEC14L4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Methotrexate	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	clofarabine	CTRPv2	pan-cancer	AAC	0.087	0.003
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.097	0.003
mRNA	masitinib	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.003
mRNA	selumetinib:BRD-A02303741 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.003
mRNA	BRD9876	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.003
mRNA	LY-2183240	CTRPv2	pan-cancer	AAC	0.09	0.004
mRNA	Doxorubicin	CTRPv2	pan-cancer	AAC	0.085	0.004

Download CSV